• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume10, Issue2

Evaluation of effect of phacoemulsification on central macular thickness and best corrected visual acuity in patients of diabetes mellitus

    Dr. Gurleen Kaur, Dr. Rajesh Kumar, Dr. Karamjit Singh, Dr. Prempal Kaur, Dr. Harkanwar Singh Arri, Dr. Amanpreet Kaur

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 2, Pages 2069-2077

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

To evaluate the effect of uncomplicated phacoemulsification on central macular thickness (CMT) and best corrected visual acuity (BCVA) in diabetic patients without diabetic retinopathy (DR) and diabetic patients with mild to moderate non proliferative diabetic retinopathy (NPDR).
Materials & methods: A total of 200 diabetic patients (200 eyes) who underwent phacoemulsification were divided into 2 groups as Group A:100 patients withoutDR and Group B:100 patients with mild to moderate NPDR. All patients entered into the study were followed up preoperatively and at 1 month, 6 months and 1 year after phacoemulsification and CMT and BCVA were evaluated at each follow up and tabulated and analyzed by suitable statistical tests.
Results: CMT of group A at postoperative 1 month and 6 months was 259.20±20.57µm and 243.48±11.11µm respectively and of group B was 280.03±34.52µm and 254.28±16.46µm respectively. There was significant difference between 2 groups at both postoperative 1 month and 6 months after uncomplicated phacoemulsification. There was no significant difference in the postoperative mean CMT at 1 year between group A (234.03±9.38µm) and group B (240.21±34.00 µm). Mean BCVA Log MAR was 0.15±0.22 in group A as compared to 0.30±0.34 in group B at postoperative 1 month, mean BCVA Log MAR was 0.13±0.12 in group A as compared to 0.20±0.20 in group B at postoperative 6 months, mean BCVA Log MAR was 0.11±0.11 in group A as compared to 0.17±0.15 in group B at postoperative 1 year. ‘p’-value was highly significant in the mean BCVA Log MAR at postoperative at 1 month,6 months and 1 year between the two groups.
Conclusion: There was significant increase in mean CMT and mean BCVA Log MAR at postoperative 1 month,6 months and 1 year in both the groups. At postoperative 1 and 6 months there was significant difference in CMT between both groups whereas there was no significant difference in CMT at 1 year between the 2 groups. At postoperative 1 month, 6 months and 1 year, there was significant difference in BCVA Log MAR between both groups.
Keywords:
    Diabetic Retinopathy Central macular thickness Phacoemulsification
  • PDF (381 K)
  • XML
(2023). Evaluation of effect of phacoemulsification on central macular thickness and best corrected visual acuity in patients of diabetes mellitus. European Journal of Molecular & Clinical Medicine, 10(2), 2069-2077.
Dr. Gurleen Kaur, Dr. Rajesh Kumar, Dr. Karamjit Singh, Dr. Prempal Kaur, Dr. Harkanwar Singh Arri, Dr. Amanpreet Kaur. "Evaluation of effect of phacoemulsification on central macular thickness and best corrected visual acuity in patients of diabetes mellitus". European Journal of Molecular & Clinical Medicine, 10, 2, 2023, 2069-2077.
(2023). 'Evaluation of effect of phacoemulsification on central macular thickness and best corrected visual acuity in patients of diabetes mellitus', European Journal of Molecular & Clinical Medicine, 10(2), pp. 2069-2077.
Evaluation of effect of phacoemulsification on central macular thickness and best corrected visual acuity in patients of diabetes mellitus. European Journal of Molecular & Clinical Medicine, 2023; 10(2): 2069-2077.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 8
  • PDF Download: 13
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus